Business
Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences
Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025.
About this update from Danaher Corporation
[{"type":"text","content":"WASHINGTON, June 27, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025.","length":342,"tagName":"p"},{"type":"text","content":"Mr. Milosevich has served as Vice President and Group Executive of the Life Sciences Innovations Group since 2021. With this expanded role, he will become an executive officer of Danaher and will continue reporting to Rainer Blair, President and Chief Executive Officer.","length":270,"tagName":"p"},{"type":"text","content":""Greg has played a pivotal role in advancing our Life Sciences Innovations Group over the past four years," said Rainer Blair. "His consistent ability to deliver results, deep customer focus and talent for building high-performing teams—combined with his strong embodiment of the Danaher Business System—make him an outstanding leader. I'm confident he will continue to drive success as he takes on this expanded role."","length":443,"tagName":"p"},{"type":"text","content":"Mr. Milosevich joined Danaher in 2010, through the acquisition of Molecular Devices, and since has held roles of increasing responsibility across multiple businesses. In his most recent role, as Vice President and Group Executive, Life Sciences Innovations Group, Mr. Milosevich oversaw multiple Danaher companies, including Beckman Coulter Life Sciences, Sciex, Leica Microsystems, Molecular Devices, Phenomenex, Abcam, IDBS and Genedata. He holds a bachelor's degree in physics from the University of Puget Sound, graduating Summa Cum Laude.","length":547,"tagName":"p"},{"type":"text","content":"ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Fo...